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Abstract 
Background: In this study we examine the integrity of the cell wall during scale up of a yeast fermentation process 
from laboratory scale (10 L) to industrial scale (10,000 L). In a previous study we observed a clear difference in the vol-
ume fraction occupied by yeast cells as revealed by wet cell weight (WCW) measurements between these scales. That 
study also included metabolite analysis which suggested hypoxia during scale up. Here we hypothesize that hypoxia 
weakens the yeast cell wall during the scale up, leading to changes in cell permeability, and/or cell mechanical resist-
ance, which in turn may lead to the observed difference in WCW. We tested the cell wall integrity by probing the cell 
wall sensitivity to Zymolyase. Also exometabolomics data showed changes in supply of precursors for the glycosyla-
tion pathway.
Results: The results show a more sensitive cell wall later in the production process at industrial scale, while the sensi-
tivity at early time points was similar at both scales. We also report exometabolomics data, in particular a link with the 
protein glycosylation pathway. Significantly lower levels of Man6P and progressively higher GDP-mannose indicated 
partially impaired incorporation of this sugar nucleotide during co- or post-translational protein glycosylation path-
ways at the 10,000 L compared to the 10 L scale. This impairment in glycosylation would be expected to affect cell 
wall integrity. Although cell viability from samples obtained at both scales were similar, cells harvested from 10 L bio-
reactors were able to re-initiate growth faster in fresh shake flask media than those harvested from the industrial scale.
Conclusions: The results obtained help explain the WCW differences observed at both scales by hypoxia-triggered 
weakening of the yeast cell wall during the scale up.
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Metabolite profiling, Hypoxia, glycosylation pathway
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Background
The scale-up of a Saccharomyces cerevisiae fermenta-
tion process from 10 to 10,000 L to produce a recombi-
nant therapeutic protein was described previously [1]. 
The successful scale-up generated comparable biomass 
as indicated by dry cell weight (DCW), and comparable 
amount of product with similar quality [2, 3]. There were, 
however, differences in manufacturing attributes, includ-
ing elevations in the weight cell weights (WCWs) and 
culture apparent viscosity at 10,000 L scale as compared 
to the 10  L scale. The oxygen transfer coefficient, kLa, 
and oxygen demand were shown to be key elements dur-
ing the scale-up. Metabolite profiling of the extracellular 
culture medium (exometabolomics) revealed that sev-
eral pathways were affected, including mevalonate and 
membrane lipid syntheses, glycolysis, the tricarboxylic 
acid (TCA) cycle, and the synthesis of branched chain 
amino acids. A common feature of these pathways is 
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their dependence on oxygen, thus their impairment could 
be explained by hypoxic conditions that developed at 
the industrial scale. Potentially, the changes in metabolic 
pathways could affect cell structure and function during 
the fermentation process. More specifically, our previ-
ous work suggested that the metabolic changes observed 
at the industrial scale could affect membrane permeabil-
ity, likely leading to higher cell volume (as can be judged 
from WCW).
There is a fundamental question of how the physiologi-
cal and metabolic behaviors of a S. cerevisiae strain pro-
ducing a recombinant protein changes in response to the 
transition from laboratory to industrial scale, 10,000  L. 
Specifically, we utilize exometabolomics to determine 
activation/inactivation of metabolic pathways and how 
they affect important physiological variables such as spe-
cific biomass and product yields but also compromising 
structurally the cell. Furthermore our results suggested 
effects due to the scale-up process on the cell wall which 
may have an impact on cell morphology, permeability, 
and resistance to mechanical forces present in highly 
stirred and aerated bioreactors thus explaining the differ-
ences in WCW.
The cell wall of S. cerevisiae represents 15 to 30  % 
of the dry weight, 25 to 50  % of the cell volume and is 
largely composed of polysaccharides and proteins [4]. 
Four classes of interacting components, including chitin, 
β 1,3 glucan, β 1,6 glucan, and mannoproteins have been 
reported [5]. The cell wall represents a dynamic struc-
ture that can adapt to physiological and morphological 
changes [6]. As a matter of fact, Aguilar-Uscanga and 
Francois [7] reported that hypoxia led to a 25 % reduction 
of the cell wall mass and to a three-fold decrease in chi-
tin content. Yeast cells with weakened cell wall elicited by 
either environmental conditions or mutations, triggered 
a compensatory mechanism that resulted in the accumu-
lation of mannoproteins, e.g. GPI-CWPs or Pir-CWPs, or 
changes in glucans, e.g. β 1,3 or β 1,6 glucan, or chitin, to 
avoid cell lysis 4, [6, 8–12].
Genetic, morphological, and biochemical evidence 
shows a critical link between N- and O-types of glyco-
sylation with the assembly and integrity of the cell wall 
in S. cerevisiae [12, 13]. Impairment of N-glycosylation 
led to β 1,6 glucan loss and a more diffused outer layer 
of the cell wall [12]. On the other hand, Willer et  al. 
[14] showed that lack of O-mannosylation can cause 
abnormal cell wall and septum formation. Our previous 
findings already showed higher levels of ergosterol pre-
cursors like 3-hydroxy-3-methylglutarate and acetoac-
etate, and membrane components like choline, glycerol 
3-phosphate, and glycerophosphorylcholine, at 10,000 L 
scale than at 10 L scale, without changes in cell viability. 
At industrial scale results indicated a defective synthesis 
of sphingolipids and ergosterol [1]. Then, it is known 
that a defective synthesis of sphingolipids and ergosterol 
impairs the incorporation of Gas1p (a GPI-anchored α-1, 
3-glucanosyltransglycosylate) to the cell wall [15], and 
consequently the reduced Gas1p incorporation increased 
cell wall porosity due to reduced β-glucan crosslinking 
[16].
Under the hypothesis that the weakening of the yeast 
cell wall arises as a result of conditions imposed by the 
scaling up process, in this study we combine exometabo-
lomics with analysis of cell wall integrity to further under-
stand the mechanisms underlying this phenomenon.
Results
Cell growth based on volume fraction occupied by cells 
and specific growth rates at two scales
There was a clear difference in the volume fraction 
occupied by cells as revealed by WCW measurements 
of yeast cultured under laboratory (10  L) versus indus-
trial (10,000  L) scales after an elapsed fermentation 
time (EFT) 60  h. Hypothetically, the observed increase 
of WCWs may be explained by an increase in cell size. 
Evidence showing cell cycle-related size change versus 
growth rate in S. cerevisiae carbon-limited chemostat 
cultures was reported previously [17, 18].
The results depicted in Fig. 1a show WCWs determined 
at 10,000  L scale trending similarly but always slightly 
higher than those at 10 L scale between EFT 33 and 55 h. 
Fig.  1b shows cells at 10  L scale growing at higher spe-
cific growth rates (µ) per CDW than those at 10,000  L 
scale. In Fig. 1a, shows that after EFT 83 h the difference 
between WCWs at the two scales was magnified whereas 
µ was not significantly different (Fig. 1b). The two verti-
cal black dashed lines in panel b indicate the transition 
phase corresponding to the accumulation of biomass. 
Before EFT 54  h, WCW accumulation increased fast at 
both scales; however, after EFT 64  h, WCW increased 
slowly at 10,000  L while leveling off at 10  L. WCW at 
10,000  L was trending higher than at 10  L during the 
whole fermentation process. Before EFT 54  h, the rates 
of CDW accumulation at 10 L and 10,000 L were 0.0345 
and 0.0252 h−1, respectively whereas after EFT 64 h the µ 
decreased dramatically to 0.0073 h−1 at both scales. Cells 
at 10,000  L could be under challenging conditions as 
reflected by similar CDWs than those measured at 10 L 
scale between EFT 60 and 83  h, but higher cell volume 
measured as WCW compared to 10 L as shown by panels 
a and b in Fig. 1.
In principle, the ensemble of data indicates that a posi-
tive correlation between growth rate based on CDW and 
cell’s volume cannot explain the results. We suspect the 
aggravating effect of hypoxia not only upon anabolism/
catabolism but also on the structure/functionality of 
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membranes and other important cellular components 
that play a key role in maintaining the yeast cell wall 
integrity thus mediating cell volume changes.
Cell wall integrity by zymolyase assay
To test whether metabolic changes triggered by hypoxic 
conditions existing at the industrial scale affected cell 
Fig. 1 Comparison of wet cell weight (a) and cell dry weight (b) at 10,000 and 10 L scale. The green and orange lines represent the temporal 
biomass accumulation profiles at 10 and 10,000 L, respectively. In b the specific growth rates are from the best linear fit of the semi-LN plot of CDW 
versus elapsed fermentation time (EFT) in hours (hr). Plotted CDW, WCW values are average of 9 and 7 batches at 10 and 10,000 L scale, respectively. 
In both panels the two parallel-dashed lines delimitate the transition time between fast- and slow-growing cells during fed-batch. Error bars repre-
sented one standard deviation
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wall integrity, we implemented a Zymolyase assay that 
probes the cell wall sensitivity to the enzyme’s activity as 
detailed in “Methods” section.
First, we comparatively examined the cell wall integrity of 
the production strain (PRD) at both scales. Samples were 
collected at EFT 46, 54, 64, 76 and 80 h, re-suspended in 
PBS, and tested for Zymolyase sensitivity. Figure  2 shows 
the results obtained with the PRD strain at 10 and 10,000 L. 
At 10 L cell lysis rates increased from 0.14 to 0.17  s−1 or 
a 21 % rise throughout the course of the fermentation. In 
contrast, at 10,000 L the PRD strain showed a rising trend 
of cell lysis rates starting at 0.15 s−1 (EFT 46 h) and up to 
0.29 s−1 thus more than 50 % increase after EFT 64 h. The 
cells from EFT 76 and 80 h were significantly more sensi-
tive to Zymolyase activity at 10,000 L than at 10 L scale.
The results obtained indicate that the PRD cell wall 
exhibits a progressive weakening as the fermentation 
process progresses at the industrial scale. These results 
suggest that the cell volume increments seen at 10,000 L 
scale could be caused by the cell wall weakness. Then our 
hypothesis that the hypoxia compromised the cell wall 
biogenesis and its integrity of those cells cultured at large 
scale needed to be investigated requiring more data from 
exometabolomics.
Other potential microorganism‑ or bioprocess‑dependent 
factors influencing cell wall sensitivity
Heterologous protein expression
We tested whether the metabolic burden introduced 
by the high expression of heterologous protein Pr-1 by 
affecting cell proliferation and cell growth, e.g. by com-
peting for key metabolic intermediates, interferes with 
cell wall biogenesis.
The PRD and Null strains were run under optimized 
production conditions at 10 L to investigate the cell wall 
sensitivity to Zymolyase (Fig. 3). Genotypically, the only 
difference between the PRD and Null strain was the pres-
ence or absence, respectively, of the Pr-1 coding region 
for the heterologous protein. The Null strain exhibited 
cell lysis rates ranging from 0.13 to 0.22  s−1 up to EFT 
64 h; and decreasing to 0.14 s−1 thereafter. Compared to 
the cell lysis rates shown by the PRD strain (from 0.14 
to 0.17  s−1, Fig. 2), there were no significant differences 
except for EFT 64 h, and the reason for this unexpected 
high cell lysis rate is unclear. However, both strains 
exhibited minimum changes in the sensitivity to Zymol-
yase over time at the 10  L scale, indicating the lack of 
contribution by the therapeutic protein expression to the 
weakening of the cell wall.
Fig. 2 Comparison of cell lysis rates (s−1) shown by the PRD strain throughout the fermentation time between scales 10 and 10,000 L scale. The 
green and orange dashed lines represent the cell lysis rates profiles at 10 and 10,000 L, respectively. Those cell lysis rates were calculated as described 
in “Methods” section. All rate determinations at 10 L were by duplicate. All rate determinations at 10,000 L were by triplicate. Error bars represented 
one standard deviation
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In addition, an ATCC strain named a null-wild type 
(WT) strain was included and used to run the same pro-
cess at 10 L to compare the level of sensitivity to Zymol-
yase with our production Null strain. Figure 3 showed the 
significant lower cell lysis rates of the WT strain when 
compared to the Null and PRD strains during the entire 
fermentation time at the same 10  L scale. Clearly these 
lysis rates are providing references of cell wall integrity 
relatively to other host not related to the PRD one. Then, 
this PRD host strain exhibited inherently lower cell wall 
integrity but hypoxia at the 10,000 L, progressively aggra-
vated it throughout the fermentation time.
Biomass yield and cell viability
As shown in Table 1, the partial volume occupied by cells, 
as reflected by WCW, was consistently 16  % higher at 
10,000 L than at 10 L (Fig. 1) by comparing PRD at both 
scales. This result is in agreement with a higher WCW/
CDW ratio for the PRD strain at 10,000 L (Table 1). How-
ever, viability and biomass yield, did not exhibit signifi-
cant differences with respect to the scale of production.
At 10 L scale, the WT strain showed higher CDW and 
WCW of 210 and 714  g/kg than 157 and 636  g/kg for 
Null production strain. These results are also reflecting in 
better biomass yields on glucose by WT host strain, 93 g/
mol, than those measured in the PRD-related host strains 
of slightly above 70  g/mol (Table  1). Using the ratio of 
WCW to CDW the WT strain exhibited the lowest ratio 
compared to the production host, indicating the least 
volume occupied by the cell per unit of biomass meas-
ured as CDW.
These results are indicating the nature of metabolic 
changes related to the cell wall biogenesis and its integ-















Cell lysis rate for PRD at 10L scale
Cell lysis rate for Null at 10L scale
Cell Lysis rate for WT at 10L scale
Fig. 3 Cell lysis rate comparisons between the production (PRD) strain, the non-producing null strain, and the wild type (WT) strain at 10 L scale. 
The green, purple, and blue dashed lines represent the cell lysis rate profiles of PRD, null, and WT, respectively, at 10 L. Those cell lysis rates were calcu-
lated as described in “Methods” section. All rate determinations were by duplicate. Error bars represented one standard deviation
Table 1 Average viability and biomass comparison between the production (PRD), the Null and wild-type (WT) strains
PRD 10,000 L, n = 4 PRD 10 L, n = 9 Null 10 L, n = 2 WT 10 L, n = 2
Viability (%) 93.1 93.0 93.6 98.0
CDW (g/kg) 143 152 157 210
WCW (g/kg) 696 602 636 714
WCW/CDW 4.87 3.96 4.05 3.40
Biomass yield (g/mol glucose) 70.2 70.2 70.8 93.4
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Production process stage
We investigated the capacity of yeast cells to reinitiate the 
mitotic cycle as a function of the bioprocess stage to, ulti-
mately, understand the metabolic bases of the PRD differ-
ences between scales. We analyzed the growth kinetics 
when yeast cell were re-grown in shake flask containing 
fresh medium. Cells were withdrawn from the production 
bioreactor at EFT 46, 64 and 82  h at both scales, resus-
pended in fresh medium and their growth kinetics evalu-
ated based on µ, the shake flask incubation time to reach 
a target OD600 of 2 (mid-exponential phase, Fig. 4) as well 
as the total glucose consumed and ethanol produced and 
their corresponding rates (Table 2). At 10,000 L scale, cells 
from EFT 46 h exhibited the highest specific growth rate 
of 0.193  h−1 whereas cells harvested later progressively 
lowered the specific growth rates from 0.171 h−1 at 64 h 
to 0.164  h−1 at 82  h. Interestingly, cells from EFT 64 or 
82 h showed longer lag phases than at EFT 46 h (19 and 
20 h versus 16.75 h, Fig. 4a). Consistently with the typi-
cal glucose over-flow metabolism known in S. cerevisiae; 
cells harvested at 46 h consumed glucose and generated 
ethanol faster as compared to 64 and 82 h (Table 2). Over-
all, the results show that cells harvested later in time were 
kinetically slower to re-initiate the mitotic cycle, exhibit-
ing approximately a delay of 2 to 3 h. 
A similar study was performed in the 10  L bioreac-
tors. As shown in Fig.  4b, cells harvested earlier grew 
faster and exhibited shorter lag phases than those har-
vested later. Those cells harvested at later EFT 64 and 
82 h exhibited the µ of 0.184 and 0.181 h−1 as shown in 
Table 2. Those cells from EFT 64 or 82 h showed longer 
(18.5  h) lag phases than those harvested at EFT 46  h 
(16.5 h) to reach same OD600 of 2. Following the typical 
glucose over-flow metabolism of S. cerevisiae; ethanol 
production rates were higher at EFT 46  h compared to 
those rates measured in late time at 10 L scale (Table 2).
When comparing between scales, however, cells har-
vested at early time points (EFT 46 and 64  h), simi-
lar growth rates, lag phase lengths, and total glucose 
consumed can be found but still glucose uptake and etha-
nol production rates are higher at 10 versus 10,000 L indi-
cating different enzyme make-ups required for glycolysis 
probably induced by the previous hypoxic conditions in 
the production bioreactor (Table 2). Additionally cells from 
10 L scale were faster to re-initiate the vegetative growth in 
shake flasks than those from 10,000 L scale, especially when 
withdrawn later from the production bioreactor (Fig. 4).
Hypoxia‑elicited impairment of glycosylation pathway 
precursors and its impact on cell wall biogenesis 
and integrity as revealed by increased leakiness
Our previous work suggested that hypoxia triggered 
down-regulation of the mevalonate pathway at the 
industrial scale as compared to the laboratory scale [1]. 
In yeast, the mevalonate pathway is important not only 
for the biosynthesis of ergosterol, the main sterol pre-
sents in cell membranes, but also for generating dolichol 
phosphate (DolP), a lipid acceptor of sugar residues, par-
ticularly mannose to form DolP mannose (DolP Man). 
This sugar-lipid intermediate is involved in the N- and 
O-glycosylation at the golgi, including the synthesis of 
the sugar part of the glycosyl phosphatidyl inositol (PGI) 
anchor as well as of proteins with internal repeats (Pir-
CWP) [5].
Several metabolic pathways are known to contrib-
ute to protein glycosylation, and intermediates of these 
pathways were scrutinized for differences over time and 
between the two scales (Fig.  5). Glucose-6-phosphate 
(G6P), fructose-6-phosphate (F6P), mannose-6-phos-
phate (Man6P), UDP-glucose (UDP Glu) and N-acetyl-
glucosamine (GlcNAc) were all consistently at lower 
levels in the 10,000 L compared to 10 L reactor thus sug-
gesting differences in protein glycosylation. More specifi-
cally, GDP-mannose (GDP-Man), an important upstream 
sugar lipid intermediate for O- and N-glycosylation, 
increased over time in 10,000 L whereas it decreased in 
the 10 L system (Fig. 6). The lower levels of Man6P and 
the progressively higher amounts of GDP-Man detected 
suggest partial impairment of protein glycosylation from 
GDP-Man at co- or post-translational glycosylation levels 
in the 10,000 versus 10 L that aggravated as a function of 
time.
Taking into consideration these results suggesting 
a cell wall integrity highly compromised, now further 
supported by more exometabolomics data showing the 
leak of key metabolites for biomass synthesis/mainte-
nance (Figs. 7, 8). The leakiness of the yeast cell walls was 
reflected by the appearance in the extracellular medium 
at 10,000 L scale of higher levels of several amino acids, 
e.g. threonine, phenylalanine, glutamine, methionine, 
tyrosine, tryptophan, valine, and glycine than those ana-
lyzed at 10  L (Fig.  7). At 10,000  L scale, there was also 
noticeable accumulation of nucleic acids, purines and 
pyrimidines, e.g. thymidine, adenosine, guanine, guano-
sine, cytosine, and uracil compared to 10 L scale (Fig. 8).
The data presented show that the glycosylation pathway 
in yeast offers many levels of possible regulation which 
might influence the cell wall integrity and so leakiness of 
metabolites. Likely, these effects may be mediated by a 
differential utilization of metabolic precursors of protein 
glycosylation occurring at the two scales.
Discussion
The main contribution of this work is a detailed charac-
terization of the effects triggered by hypoxia on the physi-
ological behavior of S. cerevisiae during the scale up of a 
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high-cell density fed-batch process for the commercial 
production of a therapeutic protein. Herein, using exo-
metabolomics, we further show that impairment of glyco-
sylation pathway triggered by hypoxia at 10,000  L affect 
the cell wall integrity of S. cerevisiae, likely due to low sup-
ply of phosphorylated sugars namely GDP mannose.
Previously, we reported on the process control 
improvement to mitigate the scaling up effect on 
performance as measured by productivity and prod-
uct quality. However, irrespective of those changes, the 
WCW and broth viscosity differences between labora-
tory and industrial scales remained. Exometabolomics 
data further revealed that those physiological differences 
could be explained by low availability of dissolved oxygen. 
Apparently, the impact of hypoxia was not only on the 
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Fig. 4 Growth curves for inoculums from 10,000 and 10 L sampled at EFT 46, 64, and 82 h. a Optical densities at 600 nm (OD600) versus incubation 
time of corresponding shake flasks inoculated with samples at EFT 46 h (pink), 64 h (brown), and 82 h (purple) from 10,000 L production bioreactors. 
b OD600 temporal profiles corresponding to shake flasks inoculated with samples at the indicated EFTs from 10 L production bioreactors. Optical 
densities at 600 nm (OD600) measured as detailed in “Methods” section. All determinations are by duplicate. Error bars represented one standard 
deviation
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Table 2 Summary of  growth kinetic, glucose consumption, and  ethanol production of  samples from  10,000 and  10  L 
scales
10,000 L 10 L
46 h 64 h 82 h  46 h 64 h 82 h
Time to reach OD = 2 (h) 16.8 18.9 20.0 16.5 18.5 18.5
Glucose consumed (g/L) 12.1 12.6 12.2 12.3 13.0 12.7
Glucose consumption rate (g/L/h) 0.722 0.664 0.608 0.745 0.700 0.686
Ethanol produced (g/L) 4.37 4.32 4.38 4.54 5.05 4.72
Ethanol production rate (g/L/h) 0.261 0.229 0.219 0.275 0.273 0.255


































































































Fig. 5 N-glycosylation linkages are derived from N-acetyl-glucosamine (GlcNAc), mannose (Man) and glucose (Glu). These sugars are added con-
secutively onto dolichol, a poly isoprenoid lipid carrier embedded in the endoplasmic reticulum (ER) membrane. 3 UDP Glu and 4 GDP Man from 
the cytoplasm were bound to dolichol first via a pyrophosphate linkage (–PP–). After the Man5GlcNAc2-PP-dolichol intermediate is completed, the 
entire complex is flipped into the lumen of the ER
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ergosterol, (ii) glycolysis/TCA cycle [1], but also included 
cell structures like (iii) the cell wall and its physico-chem-
ical properties. Zymolyase activity exposed a defect in 
the cell wall integrity at the industrial scale. Exometab-
olomics confirmed impaired function of glycosylation 
pathways that supply intermediates for cell wall biogen-
esis while indicating leak of several key building blocks 
for biomass, amino acids, nucleotides and nucleosides.
The mevalonate pathway is known to affect post-
translational modification of proteins such as protein 
glycosylation [16, 19]. Protein glycosylation requires 
DolP, which is synthesized together with other isopre-
noid lipids in the mevalonate pathway. Protein glyco-
sylation associated with the secretory pathway in S. 
cerevisiae involve attachment of N-linked saccharides 
to asparagine, O-linked mannose glycans to serine or 
threonine residues, and anchoring of glycosyl phosphati-
dyl inositol (GPI) to the –COOH terminus of membrane 
proteins [20].
N-glycosylation of protein utilizes DolP as a lipid accep-
tor of sugar residues. Within the ER, DolPP-GlcNAc-
2Man5 is converted to DolPP-GlcNAc2Man9Glu3, using 
DolP Man and dolichol phosphate glucose (DolP Glu) as 
sugar donors [21]. Also DolP Man is a substrate for pro-
tein O-mannosylation, where it serves as the donor of the 
first mannose to be attached to hydroxyl groups of serine 
and threonine in the protein. The second and subsequent 
mannose residues are transferred directly from GDP Man 
[22]. These glycoproteins are secreted into the periplasmic 
space and are incorporated into the rigid cell wall structure 
GDP-mannose








































































































Sub Pathway Biochemical Name
10L 54hrs 10L 64hrs 10L 76hrs 10L 80hrs 10000L 54hrs 10000L 64hrs 10000L 76hrs 10000L 80hrs
10L 46hrs 10L 46hrs 10L 46hrs 10L 46hrs 10000L 46hrs 10000L 46hrs 10000L 46hrs 10000L 46hrs
Protein Glycosylation Metabolites
glucose-6-phosphate (G6P) 0.89 1.19 0.56 0.79 0.78 1 0.52 0.45
glucose 1.19 1.4 1.79 1.58 1.09 1.05 1.09 1.23
UDP-glucose 0.8 1.04 0.57 0.61 1.39 1.5 1.42 1.25
fructose-6-phosphate 0.8 1.16 0.49 0.66 0.71 0.9 0.37 0.32
f ructose 1-phosphate 0.55 0.99 0.19 0.13 0.69 0.82 0.05 0.01
glucosamine 0.99 1.02 2.28 1.99 2.21 1.98 3.44 1.66
N-acetylglucosamine 0.83 1.02 1.54 1.7 0.89 0.85 0.68 0.76
mannose-6-phosphate 0.82 1.2 0.52 0.77 0.75 1.02 0.51 0.43
GDP-mannose 0.88 0.59 0.54 0.57 1.26 1.22 1.42 1.46
a
b
Fig. 6 Line plot graphs from 10 L (green line) 10,000 L (orange line) scale and the corresponding heat map table showing metabolites related to pro-
tein glycosylation pathways. a Line plots graphs of the glycosylation pathway related intermediates comparison between scales. b Heat map table. 
The heat map tables are color coded, and descriptions are shown in Additional file 1: Figure S1. The intermediates measurement and data analysis 
were determined as described in “Methods” section. Error bars represents “mean ± one standard deviation”. “M” and “F” in the time axis for every line 
plot stand for medium and feed samples, respectively
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as mannans [20]. In addition DolP Man is involved in the 
synthesis of the sugar moiety of the GPI anchor in yeast 
and other eukaryotes [20]. Therefore, a link between the 
cell wall integrity and the levels of phosphorylated sugars 
(e.g. GlcNAc 6P, glucose 6P, glucose 1P, mannose 6P), sugar 
nucleotides (e.g. UDP-GlcNAc, GDP Man, UDP Glu), and 
DolP is possible. Our exometabolomics data showed low 
levels of phosphorylated sugars, e.g. G6P, fructose 6P, and 
mannose 6P as well as GlcNAc (surrogate of GlcNAc 6P) 
at 10,000 L compared to 10 L scale (Fig. 6). Furthermore, 
the accumulation of nucleotide sugars GDP Man and UDP 
Glu pointed out a possible decrease in their utilization by 
the posttranslational glycosylation pathway, at late stages 
of the process in both scales analyzed.
A pathway diagram of metabolic pathways contribut-
ing to protein glycosylation showing significant increases 
in upstream intermediates (red arrows) and significant 
decreases in proximal intermediates (green arrows), 
which suggest potential differences the glycosylation 
pathway between the two bioreactor scales (Fig. 9). Accu-
mulation of mevalonate and GDP-mannose indicates lack 
of glycosylation intermediates utilization, suggesting par-
tial inhibition of glycosylation pathway in cells cultured 
at 10,000 L scale with respect to those at 10 L scale.
The connection of the cell wall integrity and glycosyla-
tion pathway has been reported based on genetic, mor-
phological, and biochemical evidence in S. cerevisiae [12, 































































































































































Fig. 7 Line plot graphs of amino acids in the media from 10 L (green line) and 10,000 L (orange line) fermentations. The intermediates measurement 
and data analysis were determined as described in “Methods” section. Error bars represents “mean ± one standard deviation”. “M” and “F” in the time 
axis for every line plot stand for medium and feed samples, respectively
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of the outer mannoprotein layer as compared with the 
wild-type exhibit a diffused cell wall [12]. Furthermore 
the resistance of yeast cells to Zymolyase as an indica-
tor of cell wall integrity was reported increased with the 
increased levels of β-1,6-glucan [23]. In this work we 
reported the cell wall integrity based on the cell wall sen-
sitivity to Zymolyase activity measured with cells from 
different times points and at 10 and 10,000 L scales. We 
considered these measurements based on cell lysis rates 
as reflection of the functional/structural status of the 
yeast cell wall. At 10,000  L compared to 10  L, particu-
larly at late time points, the production strain showed 
a significant increment in the cell lysis rate (Fig. 2). But 
at 10  L scale, the production (PRD) strain and the Null 
strain did not show clear increasing trends of the sensi-
tivity to Zymolyase activity throughout the fermentation 
time. Any possible contribution by the over-expression of 
the therapeutic protein to the compromise of the cell wall 
integrity was not found (Fig. 3). Then the metabolic bur-
den represented by the significant expression of the het-
erologous protein of interest mostly affected yeast cells 
by slowing down growth after EFT 64 h but not compro-
mising the cell wall integrity.
Taking into consideration the significant difference 
of the cell lysis rate at late time points between scales 
proved the hypothesis about the cell wall integrity being 
affected by hypoxia. Comparatively to other host strains, 

























































































































































Fig. 8 Line plot graphs of several nucleic acids in the media from 10 L (green line) and 10,000 L (orange line) fermentations. The intermediates meas-
urement and data analysis were determined as described in “Methods” section. Error bars represents “mean ± one standard deviation”. “M” and “F” in 
the time axis for every line plot stand for medium and feed samples, respectively
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included and found out the significant lower cell lysis 
rates when compared to the Null and PRD strains dur-
ing the entire fermentation time at the same 10 L scale. 
Then the wild type strain exhibited the lowest WCW/
CDW ratio compared to the production host, indicating 
the least volume occupied by the cell per unit of biomass. 
This result, combined with a higher resistance to Zymol-
yase activity demonstrated the correlation between cell 
wall integrity and the relative volume occupied by cells.
The data reported in this study proved that hypoxia 
aggravated the cell wall integrity when the process was 
scaled-up to 10,000  L and even more clear seen at the 
late time points. Furthermore, metabolomics data sup-
ported the idea of a compromised cell wall integrity as 
reflected in the leakiness of key biomass intermediates 
in late time points at 10,000  L higher extracellular lev-
els of several amino acids and nucleic acids than those at 
10 L scale (Figs. 7, 8). Then those cell volume increments 
seen at 10,000 L scale could be explained by the cell wall 
weakness and so compromising the four major functions: 
(i) stabilization of internal osmotic conditions resulting 
in limiting water influx, (ii) protection against physical 
stress, or external hydrostatic pressure (iii) scaffold to 
external layer of highly mannosylated proteins, and (iv) 
maintenance of cell shape [24]. Considering the situa-
tion of yeast’s weaken cell wall, the high hydrostatic pres-
sure and sheer stress present at the industrial scale could 
contributed to cell volume changes and significant leaki-
ness of key intracellular metabolites, in addition to the 
hypoxic conditions. Further investigation is required to 
document morphological and biochemical changes dur-
ing the yeast life cycle at both fermentation scales.
We examine the impact of hypoxia on the reversibility 
and magnitude of the cell structural/functional impact. 
When cells were removed from different fermentation 
scales and re-initiated growth in fresh media, the revers-
ibility of the functional/structural impact by hypoxia was 
revealed. There was also positive correlation between the 
length of the cell exposure to hypoxia under the indus-
trial process conditions and the time to re-initiate the 
vegetative growth in shake flasks (Fig.  4). Underlying 
this correlation, there is possibly a fundamental connec-
tion between the specific growth rate, the relative volume 
occupied by the cells, and the magnitude of the structural/
functional cell impairment. Aon and Cortassa described a 



























Fig. 9 Pathway diagram of precursor synthesis for protein glycosylation and mevalonate pathway. Results show increases in upstream intermedi-
ates (red arrows) and significant decreases in proximal intermediates (green arrows) between the two scales, 10 and 10,000 L
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phase of S. cerevisiae life cycle [17]. Longer cells lagging in 
G0/G1 phase correlated with lower specific growth rates. 
Additionally flow cytometry and fluorescence microscopy 
results showed either low percentages of budded cells or 
those with a single content of DNA per cell when a wild 
type strain was grown at low dilution rates in chemostat 
cultures [17]. These findings plus the results in this study 
could be explained by a connection between the specific 
growth rate, the WCW, and the magnitude of the struc-
tural/functional cell impairment. As shown in our Fig. 4; 
Table 2 at both scales the specific growth rates were lower 
at later, from EFTs 64 and 80  h, than early time points 
suggesting the possible longer residence of yeast cells in 
G0/G1 phase with a consequent growth in cell volume 
as reflected by the measurements of volume fractions 
occupied by cells at both scales [17, 18]. But the differ-
ence at 10,000  L scale where those WCWs were larger 
than those measured at 10 L indicate the contribution can 
be explained by the impairment of the metabolic path-
way functionalities and cell wall integrity induced by the 
hypoxia phenomenon. Furthermore, we could discern 
specifically by combining the contributions of both: (i) the 
10,000 L industrial scale and (ii) the very late time point, 
80 h versus 64 h, the higher cell lysis rates as reflection cell 
wall integrity impacted on a longer lag phase or time to 
re-initiate growth in shake flasks (Fig.  4a). At 10  L cells 
harvested at both time points, 64 and 82 h, exhibited no 
difference in the time to reach OD600 2 and the specific 
growth rates (Fig. 4b; Table 2), but at 10,000 L, there were 
differences in both same variables indicating the presence 
cells with severely compromised cell wall and unbalanced 
cell energy metabolism.
The inclusion of the temporal profiles of glucose con-
sumption and ethanol production augmented the idea 
when levels of oxygen and fresh media components 
are re-established, the yeast cells with weaker cell walls 
harvested from late fermentation time point 80  h, took 
longer to re-establish the intracellular milieu favorable 
to pass G0/G1 phase and re-start the vegetative growth. 
Another point to include in this discussion, as reported 
here and in our previous publication [1], at 10,000 L scale 
cells exposed to a more severe hypoxia supported by the 
increasing impairment of oxidative phosphorylation pos-
sibly induced the arrest of vegetative (proliferation) cell 
growth, having a larger population increasing their cell 
volume.
Conclusions
We have reported how this environmental condition, 
hypoxia, generated at industrial scale, induced physiolog-
ical changes explaining the differences in the manufactur-
ing attribute wet cell weight. Exometabolomics and cell 
wall integrity based on sensitivity to Zymolyase gave us 
an important insight to understand the metabolic path-
ways impairments as their connection to the compro-
mised cell wall integrity. Both sets of results supported (i) 
the observed delays to re-establishing vegetative growth 
under favorable conditions and (ii) the greater cell leaki-
ness in the late time points in this particular fermenta-
tion process at industrial scale.
Methods
Strains
The S. cerevisiae production strain (PRD) was originally 
developed from the parental S. cerevisiae strain AH22 
(ATCC 38626), with the gene encoding the product (Pr-
1) in a high-copy plasmid [1]. Host strain was express-
ing and secreting the Pr-1 molecule under a glucose 
limiting condition. Null strain in this study refers to the 
same strain but with the plasmid lacking the encoding 
sequence for Pr-1. Wild type strain used in this study was 
ATCC YHS74 (MATa cir leu2-3,-112 pep4-3 prb1-1122 
prc1-407), and YHS74 was engineered on ura3-52 muta-
tion reversion from ATCC’s AB122 strain.
10 L fermentation process
The details of the 10 and 10,000  L scale have been 
reported before [1]. Briefly, the seed train started in a 
shake flask incubated and agitated in a rotary shaker at 
30 °C and 225 rpm until glucose was depleted. Then the 
flask culture was used to inoculate a seed bioreactor (Bio-
lafitte, Saint Germain en Laye, France) to achieve higher 
cell density with the following set points: backpressure 10 
psi, dissolve oxygen (DO) 30 %, pH 6.0 and temperature 
29 °C. This seed stage consisted of a batch phase followed 
by a fed-batch phase using glucose nutrient feed. The pH 
and DO control loops were the same as described before 
via Distributed Control System (DCS, Siemens Moore 
APACS, US) [1]. DO was controlled at a cascade system 
of automatically first ramping up agitation until the max-
imum (900  rpm), and then injecting pure oxygen being 
blend into the inflowing air fixed at a total gas sparge 
rate if needed. The pH was controlled using ammonium 
hydroxide (30  %) and phosphoric acid (17  %) additions. 
Once the target optical density (OD600) of 100 ± 20 was 
reached, the culture was used to inoculate a 10  L pro-
duction bioreactor with a target inoculation of OD600 
15. The production process was a similar process to the 
seed expansion with backpressure 10 psi, DO 12.5 %, pH 
5.75 and temperature 29 °C. A glucose nutrient feed and 
a phosphate salt solution feed were both initiated when 
glucose concentration was ≤0.3 g/L in the batch medium. 
The shake flask medium [modified buffered minimal 
medium (BMM)], seed media (modified MW10 medium) 
and feed media (modified MW10 medium) were the 
same as described in Fu et al. [1]. Samples were taken at 
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certain intervals to monitor biomass, as well as metabo-
lites such as glucose and ethanol. Glucose and ethanol 
concentration was measured offline with a YSI biochem-
istry analyzer (YSI, OH, US). OD600, WCW, DCW and so 
on were tested as in the analytical method section. The 
fermentation process was terminated after 80  h of fed-
batch time. At pre-determined time points, fermenta-
tion supernatants and pellet samples were collected for 
metabolite profiling and Zymolyase assay, respectively.
10,000 L fermentation process
A full seed train was implemented, including two stages 
of shake flask cultures and two stages of seed bioreactors. 
The scale-dependent process parameters such as batch 
volume, glucose nutrient and phosphate salt feed rates as 
well as total gas flow rate were accordingly up-scaled as 
detailed in Fu et al. [1]. At pre-determined time points, fer-
mentation supernatants and pellet samples were collected 
for metabolite profiling and Zymolyase assay, respectively.
Wet cell weight and cell dry weight determination
At periodic intervals, samples were taken for determi-
nation of wet cell weight (WCW) and cell dry weight 
(CDW). The details of WCW and CDW determinations 
are detailed in Fu et al. [1].
Accumulation of CDW (µ) was also calculated in this 
study, following
where t1, t2 represent the time of sampling and CDW1, 
CDW2 are the CDWs taken at t1, t2
Growth kinetics in shake flask exhibited by cells from 10 
to 10,000 L bioreactors
Samples from 10 L or 10,000 L bioreactors were taken at 
pre-determined elapsed fermentation times (EFT), 46, 
64 and 82 h, were diluted to OD 45.15 using fresh shake 
flask medium, and then used as inocula for studying 
growth. 1  mL inoculum was added to 300  mL of shake 
flask medium (BMM) contained in a 1  L shake flask. 
Samples were taken from the shake flask aseptically every 
2 to 3 h as needed until OD 2 was reached. OD, glucose 
and ethanol concentrations were measured for the sam-
ples from shake flasks. The experiments were performed 
in duplicate, and all values reported are averages.
Specific growth rate (µ) was calculated according to
where t1, t2 represent the time of sampling, OD1 and OD2 
are the ODs taken at t1 and t2
µ = ln (CDW2/CDW1)/(t2 − t1)
µ = ln (OD2/OD1)/(t2 − t1)
Zymolyase assay for cell wall integrity
Zymolyase assay was used to obtain the cell lysis rate, 
which indicates the weakness of yeast cell wall. Then the 
cell wall integrity was evaluated by Zymolyase defined as 
a cocktail of 1, 3-β-glucanase and protease activities com-
monly used to degrade yeast cell walls [25, 26]. The pro-
tocol was modified from Aguilar-Uscanga and Francois 
[13]. The higher the cell lysis rate the weaker the cell wall. 
Samples were tested for Zymolyase sensitivity by dilut-
ing fresh culture sample in 10 mM Tris–HCl (pH 7) to a 
final optical density at 600 nm (OD600) of approximately 
0.4. The Tris buffer contained 0.25 µg of Zymolyase 100T 
(MP Biomedicals) per ml. Subsequently, the decrease of 
the OD600 was monitored for every 15 min in an hour.
Calculation of cell lysis rate using the following
Ln (ODt) is the natural log of the OD600 of vial at time 
t; Ln (OD0) is the natural log of the OD600 of the vial at 
time 0; Δ time is the total time of incubation. The plot-
ted logarithmic graph of the OD600 values gives the slope, 
which is considered the cell lysis rate.
Other analytical methods
As for OD600, samples were taken at regular intervals and 
were measured using a Beckman coulter model DU720 
spectrophotometer. Broth samples were diluted appro-
priately with dH2O to give a raw OD600 value between 0.1 
and 0.4 and were corrected with the dilution factor.
The S. cerevisiae cell viability was measured using a 
BD FACS Calibur Flow Cytometer (BD Bioscience, San 
Jose, CA, US) with some modifications [1]. Samples 
taken from the culture were immediately diluted with 
phosphate buffered saline (PBS; pH 7.2) to a final con-
centration of ~106  cells  mL−1 and stained with the red 
fluorescence dye, propidium iodide (PI). This fluorophore 
only stains the DNA of nonviable cells. The cell viability 
was reported as the inverse of the percentage of PI-posi-
tive cells with respect to the total number of cells.
Metabolite profiling
Study design
Samples were obtained from both 10 L and 10,000 L bio-
reactors. A total of five media replicates (or spent media) 
for each scale were collected at EFT 46, 54, 64, 76 and 
80 h, and frozen at −80 °C, and later analyzed for metab-
olite profiling at Metabolon, Inc. (Durham, NC, US). 
Additionally, one batch medium sample and one glucose 
feed sample were included for reference. A total of 52 
samples were analyzed.
Cell lysis rate (min−1) = [Ln(ODt)− Ln(OD0)]� time
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Sample preparation
Spent medium samples were thawed on ice, and a 100 μL 
volume sample was used for extraction. Samples were 
prepared for the appropriate instrument, either liquid 
chromatography/mass spectrometry/mass spectrometry 
(LC/MS/MS) or gas chromatography/mass spectrometry 
(GC/MS) as described in Fu et al. [1].
Liquid chromatography/mass spectrometry and gas 
chromatography/mass spectrometry
The LC/MS portion of the platform incorporated a 
Waters Acquity UHPLC system and a Thermo-Finni-
gan LTQ mass spectrometer, including an electrospray 
ionization source and linear ion-trap mass analyzer 
were used to analyze all the samples. Aliquots of sam-
ples which were vacuum-dried, reconstituted; and run 
through the different analytical chromatographic col-
umns are detailed in Fu et al. [1].
Compound identification, quantification, and data curation
Metabolites were identified by automated comparison of 
the ion features in the experimental samples to a refer-
ence library of over 3000 purified, authenticated chemical 
standard entries that include retention time, molecular 
weight (m/z), preferred adducts, and in-source fragments 
as well as their associated MS/MS2 spectra. In brief, sam-
ples were extracted and split into equal parts for analysis 
on the GC/MS and two LC/MS/MS platforms. Propri-
etary software was used to match ions to the in-house 
library of standards for metabolite identification and for 
metabolite quantization by peak area integration.
Data collection, normalization and visualization
A client matrix composed of small aliquots of all sam-
ple extracts in this study was created. The client matrix 
technical replicate samples were treated independently 
throughout the process. All process samples (client 
matrix, and a mixture of organic components used to 
assess GC column performance, process blanks, etc.) 
were spaced evenly among the injections for each day 
and all samples were randomly distributed throughout 
each day’s run. Data were collected over multiple plat-
form run days and thus, ‘block normalized’ by calculating 
the median values for each run-day block for each indi-
vidual compound. This minimizes any inter-day instru-
ment gain or drift, but does not interfere with intra-day 
sample variability. Missing values (if any) were assumed 
to be below the level of detection for that biochemical 
with the instrumentation used and were imputed with 
the observed minimum for that particular biochemical.
For visualization of biochemical differences between 
the various treatment groups, the data are displayed in 
line plot graph format and scaled such that the median 
value measured across all samples set to 1.0. The data 
selected for display by line plot were filtered by statistics 
or included for completion of a biochemical pathway.
Data statistical analyses
Biochemical data were analyzed by Welch’s two-sample 
t-tests to test that the means of two independent groups 
are equal. The heat map tables are color coded, and 
descriptions are shown in Additional file  1: Figure S1. 
Often Welch’s correction was applied to allow for une-
qual variances between the groups. The p value relates 
the probability of obtaining a result as or more extreme 
than the observed data; a low p value (p ≤ 0.05) is gener-
ally accepted as strong evidence that the two means are 
different. The q value describes the false discovery rate; a 
low q value (q ≤ 0.10) is an indication of high confidence 
in a result.
In the case of the pathway heat map table, this for-
mat is associated with the statistical analysis of the data. 
Statistical cut-offs are typically employed for determin-
ing candidate metabolites that might be physiologically 
significant in a given study. The relatively conservative 
criteria of p  ≤  0.05 and q  ≤  0.10 are routinely used in 
metabolomics studies, which allows for the identification 
of metabolites that are significantly altered in response to 
a treatment or significantly different between two com-
parison groups and would be expected to yield a false 
discovery rate of no more than 10 %. For the purposes of 
this study, comparisons between the various treatment 
groups were taken as significant when p ≤ 0.05, regard-
less of the q value. This approach was taken in order to be 
more inclusive of data that otherwise might not meet the 
strict statistical cut-off values.
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feed media “F” = grey point). B) Heat map table analysis.
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